查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1483115

核酸分离与纯化市场评估：依产品、类型、方法、应用、最终使用者、地区、机会、预测，2017-2031 年

Nucleic Acid Isolation and Purification Market Assessment, By Product, By Type, By Method, By Applications, By End-users, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 233 Pages | 商品交期: 3-5个工作天内

价格

全球核酸分离和纯化市场规模预计将从 2023 年的 48.9 亿美元增长到 2031 年的 91 亿美元，在 2024-2031 年的预测期内复合年增长率为 8.06%。该市场的成长得益于医疗保健行业的扩张、遗传疾病负担的增加、核酸分离和纯化技术的进步以及分子诊断需求的不断增长。

包括癌症在内的各种遗传疾病在世界各地区的负担日益加重，是全球核酸分离纯化市场的主要趋势之一。根据美国国家癌症研究所估计，2022年全球将通报约2,000万新发癌症病例。到 2040 年，这一数字预计将增至 2,990 万。这种成长推动了研究机构对核酸分离纯化设备和试剂盒的需求，因为研究核酸可以帮助研究人员深入瞭解此类疾病。研究有助于提高我们对此类疾病背后遗传机制的理解，从而能够开发新的干预措施、早期诊断测试和新的治疗方法。

技术进步，包括自动化核酸分离和纯化系统的开发，正在扩大全球核酸分离和纯化市场的规模。在处理高纯度样品时，对提高通量、精度和再现性的需求不断增长，推动了开发此类设备的努力。

该报告研究了全球核酸分离和纯化市场，并提供了市场概述，包括依产品类型、方法、应用、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第一章研究方法论

第二章 专案范围与定义

第三章执行摘要

第四章 2017-2031年全球核酸分离纯化市场展望

  • 市场规模及预测
  • 依产品
  • 依类型
  • 依方法
  • 依用途
  • 依最终用户
  • 依地区
  • 依公司划分的市占率 (%)，2023 年

第五章 2017-2031 年全球核酸分离纯化市场展望（依地区）

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章 市场测绘，2023 年

第七章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

第九章 监理架构与创新

第十章 主要与企业状况

第11章价格分析

第十二章案例研究

第十三章 主要进入者展望

  • QIAGEN N.V
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE HealthCare Technologies, Inc.
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Promega Corporation
  • Takara Bio, Inc.

第十四章 战略建议

第十五章 查询及免责声明

Product Code: MX11353

Global nucleic acid isolation and purification market is projected to witness a CAGR of 8.06% during the forecast period 2024-2031F, growing from USD 4.89 billion in 2023 to USD 9.1 billion in 2031F. The growth of the market is supported by the expansion of healthcare sector, increasing burden of genetic diseases, technological advancements in nucleic acid isolation and purification, and rising requirement from molecular diagnostics.

The increasing burden of various genetic diseases, including cancer, in various regions across the globe is one of the major global nucleic acid isolation and purification market trends. According to the estimates of the National Cancer Institute, in 2022, approximately 20 million new cases of cancer were reported across the globe. By 2040, the number is expected to increase to 29.9 million. The rise is propelling the requirement for nucleic acid isolation and purification instruments and kits from research institutes as studying nucleic acids helps researchers gain insights into such diseases. The research aids in improving the understanding of genetic mechanisms behind such conditions, enabling the development of novel interventions, early diagnostic tests, and new treatments.

Advancements in technology, including the development of automated nucleic acid isolation and purification systems, are bolstering the global nucleic acid isolation and purification market size. Rising efforts to develop such devices can be attributed to the growing requirement for increased throughput, accuracy, and reproducibility while processing samples with a high degree of purity.

Various companies are investing towards the development of modular instruments that are capable of working together with the help of connected software for addressing complete workflows including, extraction, sample preparation, and downstream preparation of nucleic acids that have been purified for several applications. The isolation of high-quality nucleic acids is essential for various downstream applications including genetic engineering, life sciences, forensics, diagnostics, and sequencing.

Expansion of Molecular Diagnostics Sector Boosts Market Demand

The rising requirement for molecular diagnostics is boosting the global demand for nucleic acid isolation and purification. The growing requirement of molecular diagnostics can be attributed to their increasing utilization in guiding patient management, treatment, and diagnosis, particularly in the arena of congenital abnormalities, cancer, and infectious diseases. The rising requirement for molecular diagnostics is supported by the increasing awareness about the benefits offered by personalized medicines and growing prevalence of chronic diseases.

According to the estimates of the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six out of ten Americans live with at least one chronic health condition. Molecular diagnostics is essential for improving the treatment and diagnosis of a broad range of diseases, resulting in better patient outcomes. Thus, the growing requirement for molecular diagnostics will propel the demand for nucleic acid isolation and purification kits and instruments.

Increasing Emphasis on Research and Development Activities

The rising investments by various organizations towards research and development activities are providing lucrative growth opportunities to the market. Such activities allow the development of novel technologies that support the expansion of the market. For instance, in February 2023, BioEcho Life Sciences announced they had received two new patents from the Japan Patent Office and the United States Patent and Trademark Office. The patent called "Rapid purification of high-quality nucleic acids from biological samples" will aid the company in strengthening its intellectual property portfolio. The EchoLUTION technology developed by the company supports DNA and RNA extraction in a single centrifugation step. The patent strengthens the company's position as a transformation driver for various processes in biopharmaceutical research, academics, and molecular diagnostics. Such developments are expected to support the expansion of the market in the coming years.

North America Accounts for a Significant Market Share

The expansion of the market in North America is supported by the increasing investments by the government and research institutes towards molecular biology and genomics, rapid growth of the pharmaceutical and biotechnology sectors in the region, and strong presence of various market players. The consistent research and development efforts coupled with the presence of a favorable regulatory framework is boosting the growth of North America nucleic acid isolation and purification market. The increasing investments in biotechnology sector is expected to boost the requirement for nucleic acid isolation and purification kits and instruments in the coming years. In 2023, the biotech firms in the United States attracted a total funding of USD 56.79 billion. The rising requirement for personalized medicines due to the rapid expansion of the healthcare sector is another major factor augmenting the growth of the market in the region.

DNA Isolation and Purification Expected to Witness Significant Growth

The expansion of the segment can be attributed to the importance of DNA extraction in studying the different genetic causes associated with a disease. It is important for developing diagnostics and drugs, carrying out sequencing genomes, and detecting viruses and bacteria, among others. The introduction of novel products by various leading market players is another major factor supporting the expansion of the segment. In May 2024, One BioMed launched X8 HMW DNA Cartridge Kits. The kits are capable of extracting high molecular weight (HMW) DNA in an automated manner, for usage in genome assembly and long-read sequencing. The kit is the world's first automated platform to extract high molecular weight DNA from various sample types such as cell culture, peripheral blood mononuclear cells, bacteria, etc. The company's patented Xceler8 technology is expected to redefine nucleic acid extraction by utilizing a rapid and gentle chemistry-based approach for selectively binding, clustering, and purifying intact DNA with the help of controlled fluidics.

Hospitals and Diagnostic Centers Hold Significant Market Share

The rising requirement for nucleic acid isolation and purification instruments and kits from the hospitals and diagnostic centers can be attributed to the growing prevalence of various genetic diseases and disorders across the globe. According to the estimates of the National Health, Lung, and Blood Institute, in a year, sickle cell amenia affects approximately 20 million individuals across the globe. Hospitals and diagnostic centers are heavily investing in advanced and innovative diagnostic equipment to enhance the care and services provided to the patients. RNA and DNA purification and isolation techniques are some of the efficient techniques that are deployed for diagnosing various genetic diseases inducing cystic fibrosis, sickle cell anemia, down's syndrome, and others. Furthermore, the growing emergence of new diagnostic assays and rising requirement for point-of-care testing is augmenting the demand for nucleic acid isolation and purification processes that can be easily incorporated with the diagnostic workflow, providing lucrative growth opportunities to the market.

Future Market Scenario (2024 - 2031F)

According to nucleic acid isolation and purification market analysis, the market is expected to witness significant growth in the coming years due to the increasing popularity of nucleic acid-based diagnostics and the rapid expansion of the pipeline for RNA therapeutics. The increasing utilization of sequencing platforms for clinical diagnostics and rising research and development activities will further expand the market. The growing number of genetic and infectious diseases is expected to boost the demand for nucleic acid isolation and purification instruments and kits for diagnostic applications.

Key Players Landscape and Outlook

The major players in the nucleic acid isolation and purification market are QIAGEN N.V., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Danaher Corporation. The introduction of novel instruments and technologies by leading market players is expected to provide lucrative growth opportunities for the market. In December 2023, Thermo Fisher Scientific Inc. launched an automated nucleic acid purification instrument called Thermo Scientific KingFisher Apex Dx. The product is expected to provide laboratories with in vitro diagnostic regulation approved sample prepared solutions for boosting the confidence in downstream results. The system automates the extraction of RNA, DNA, protein, and cell samples by offering IVD and RUO software modes.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Nucleic Acid Isolation and Purification Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Product
    • 4.2.1.Instruments
      • 4.2.1.1.Manual
      • 4.2.1.2.Automatic
    • 4.2.2.Kits and Reagents
  • 4.3.By Type
    • 4.3.1.RNA Isolation and Purification
      • 4.3.1.1.mRNA Isolation and Purification
      • 4.3.1.2.miRNA Isolation and Purification
      • 4.3.1.3.Total RNA Isolation and Purification
      • 4.3.1.4.Others
    • 4.3.2.DNA Isolation and Purification
      • 4.3.2.1.Genomic DNA Isolation and Purification
      • 4.3.2.2.Viral DNA Isolation and Purification
      • 4.3.2.3.Plasmid DNA Isolation and Purification
      • 4.3.2.4.Others
  • 4.4.By Method
    • 4.4.1.Column-based
    • 4.4.2.Reagent-based
    • 4.4.3.Magnetic Beads
    • 4.4.4.Others
  • 4.5.By Applications
    • 4.5.1.Diagnostics
    • 4.5.2.Precision Medicine
    • 4.5.3.Drug Discovery and Development
    • 4.5.4.Agriculture and Animal Research
    • 4.5.5.Others
  • 4.6.By End-users
    • 4.6.1.Academic and Research Institutes
    • 4.6.2.Hospitals and Diagnostic Centers
    • 4.6.3.Contract Research Organizations
    • 4.6.4.Pharmaceutical and Biotechnology Companies
    • 4.6.5.Others
  • 4.7.By Region
    • 4.7.1.North America
    • 4.7.2.South America
    • 4.7.3.Europe
    • 4.7.4.Asia-Pacific
    • 4.7.5.Middle East and Africa
  • 4.8.By Company Market Share (%), 2023

5.Global Nucleic Acid Isolation and Purification Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product
      • 5.1.2.1.Instruments
        • 5.1.2.1.1.Manual
        • 5.1.2.1.2.Automatic
      • 5.1.2.2.Kits and Reagents
    • 5.1.3.By Type
      • 5.1.3.1.RNA Isolation and Purification
        • 5.1.3.1.1.mRNA Isolation and Purification
        • 5.1.3.1.2.miRNA Isolation and Purification
        • 5.1.3.1.3.Total RNA Isolation and Purification
        • 5.1.3.1.4.Others
      • 5.1.3.2.DNA Isolation and Purification
        • 5.1.3.2.1.Genomic DNA Isolation and Purification
        • 5.1.3.2.2.Viral DNA Isolation and Purification
        • 5.1.3.2.3.Plasmid DNA Isolation and Purification
        • 5.1.3.2.4.Others
    • 5.1.4.By Method
      • 5.1.4.1.Column-based
      • 5.1.4.2.Reagent-based
      • 5.1.4.3.Magnetic Beads
      • 5.1.4.4.Others
    • 5.1.5.By Applications
      • 5.1.5.1.Diagnostics
      • 5.1.5.2.Precision Medicine
      • 5.1.5.3.Drug Discovery and Development
      • 5.1.5.4.Agriculture and Animal Research
      • 5.1.5.5.Others
    • 5.1.6.By End-users
      • 5.1.6.1.Academic and Research Institutes
      • 5.1.6.2.Hospitals and Diagnostic Centers
      • 5.1.6.3.Contract Research Organizations
      • 5.1.6.4.Pharmaceutical and Biotechnology Companies
      • 5.1.6.5.Others
    • 5.1.7.United States*
      • 5.1.7.1.Market Size & Forecast
        • 5.1.7.1.1.By Value
        • 5.1.7.1.2.By Volume
      • 5.1.7.2.By Product
        • 5.1.7.2.1.Instruments
          • 5.1.7.2.1.1.Manual
          • 5.1.7.2.1.2.Automatic
        • 5.1.7.2.2.Kits and Reagents
      • 5.1.7.3.By Type
        • 5.1.7.3.1.RNA Isolation and Purification
          • 5.1.7.3.1.1.mRNA Isolation and Purification
          • 5.1.7.3.1.2.miRNA Isolation and Purification
          • 5.1.7.3.1.3.Total RNA Isolation and Purification
          • 5.1.7.3.1.4.Others
        • 5.1.7.3.2.DNA Isolation and Purification
          • 5.1.7.3.2.1.Genomic DNA Isolation and Purification
          • 5.1.7.3.2.2.Viral DNA Isolation and Purification
          • 5.1.7.3.2.3.Plasmid DNA Isolation and Purification
          • 5.1.7.3.2.4.Others
      • 5.1.7.4.By Method
        • 5.1.7.4.1.Column-based
        • 5.1.7.4.2.Reagent-based
        • 5.1.7.4.3.Magnetic Beads
        • 5.1.7.4.4.Others
      • 5.1.7.5.By Applications
        • 5.1.7.5.1.Diagnostics
        • 5.1.7.5.2.Precision Medicine
        • 5.1.7.5.3.Drug Discovery and Development
        • 5.1.7.5.4.Agriculture and Animal Research
        • 5.1.7.5.5.Others
      • 5.1.7.6.By End-users
        • 5.1.7.6.1.Academic and Research Institutes
        • 5.1.7.6.2.Hospitals and Diagnostic Centers
        • 5.1.7.6.3.Contract Research Organizations
        • 5.1.7.6.4.Pharmaceutical and Biotechnology Companies
        • 5.1.7.6.5.Others
    • 5.1.8.Canada
    • 5.1.9.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product
  • 6.2.By Type
  • 6.3.By Method
  • 6.4.By Applications
  • 6.5.By End-users
  • 6.6.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.QIAGEN N.V.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Agilent Technologies, Inc.
  • 13.3.Thermo Fisher Scientific Inc.
  • 13.4.Bio-Rad Laboratories, Inc.
  • 13.5.Danaher Corporation
  • 13.6.GE HealthCare Technologies, Inc.
  • 13.7.Merck KGaA
  • 13.8.F. Hoffmann-La Roche Ltd
  • 13.9.Promega Corporation
  • 13.10.Takara Bio, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 4.Global Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 5.Global Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 6.Global Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 7.Global Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 8.Global Nucleic Acid Isolation and Purification Market Share (%), By Region, 2017-2031F
  • Figure 9.North America Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 10.North America Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 11.North America Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 12.North America Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 13.North America Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 14.North America Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 15.North America Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 16.North America Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
  • Figure 17.United States Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 18.United States Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 19.United States Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 20.United States Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 21.United States Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 22.United States Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 23.United States Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 24.Canada Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 25.Canada Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 26.Canada Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 27.Canada Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 28.Canada Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 29.Canada Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 30.Canada Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 31.Mexico Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 32.Mexico Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 33.Mexico Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 34.Mexico Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 35.Mexico Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 36.Mexico Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 37.Mexico Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 38.Europe Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 39.Europe Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 40.Europe Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 41.Europe Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 42.Europe Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 43.Europe Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 44.Europe Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 45.Europe Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
  • Figure 46.Germany Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.Germany Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.Germany Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 49.Germany Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 50.Germany Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 51.Germany Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 52.Germany Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 53.France Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 54.France Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 55.France Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 56.France Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 57.France Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 58.France Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 59.France Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 60.Italy Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Italy Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 62.Italy Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 63.Italy Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 64.Italy Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 65.Italy Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 66.Italy Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 67.United Kingdom Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 68.United Kingdom Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 69.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 70.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 71.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 72.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 73.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 74.Russia Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 75.Russia Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 76.Russia Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 77.Russia Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 78.Russia Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 79.Russia Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 80.Russia Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 81.Netherlands Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 82.Netherlands Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 83.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 84.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 85.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 86.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 87.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 88.Spain Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Spain Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Spain Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 91.Spain Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 92.Spain Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 93.Spain Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 94.Spain Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 95.Turkey Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 96.Turkey Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 97.Turkey Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 98.Turkey Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 99.Turkey Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 100.Turkey Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 101.Turkey Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 102.Poland Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.Poland Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 104.Poland Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 105.Poland Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 106.Poland Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 107.Poland Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 108.Poland Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 109.South America Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 110.South America Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 111.South America Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 112.South America Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 113.South America Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 114.South America Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 115.South America Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 116.South America Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
  • Figure 117.Brazil Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 118.Brazil Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 119.Brazil Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 120.Brazil Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 121.Brazil Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 122.Brazil Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 123.Brazil Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 124.Argentina Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 125.Argentina Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 126.Argentina Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 127.Argentina Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 128.Argentina Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 129.Argentina Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 130.Argentina Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 131.Asia-Pacific Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 132.Asia-Pacific Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 133.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 134.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 135.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 136.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 137.Asia- Pacific Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 138.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
  • Figure 139.India Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 140.India Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 141.India Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 142.India Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 143.India Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 144.India Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 145.India Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 146.China Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 147.China Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 148.China Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 149.China Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 150.China Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 151.China Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 152.China Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 153.Japan Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 154.Japan Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 155.Japan Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 156.Japan Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 157.Japan Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 158.Japan Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 159.Japan Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 160.Australia Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 161.Australia Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 162.Australia Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 163.Australia Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 164.Australia Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 165.Australia Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 166.Australia Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 167.Vietnam Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 168.Vietnam Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 169.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 170.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 171.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 172.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 173.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 174.South Korea Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 175.South Korea Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 176.South Korea Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 177.South Korea Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 178.South Korea Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 179.South Korea Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 180.South Korea Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 181.Indonesia Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.Indonesia Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 184.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 185.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 186.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 187.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 188.Philippines Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 189.Philippines Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 190.Philippines Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 191.Philippines Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 192.Philippines Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 193.Philippines Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 194.Philippines Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 195.Middle East & Africa Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 196.Middle East & Africa Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 197.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 198.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 199.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 200.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 201.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 202.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
  • Figure 203.Saudi Arabia Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 204.Saudi Arabia Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 205.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 206.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 207.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 208.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 209.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 210.UAE Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 211.UAE Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 212.UAE Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 213.UAE Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 214.UAE Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 215.UAE Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 216.UAE Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 217.South Africa Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
  • Figure 218.South Africa Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
  • Figure 219.South Africa Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
  • Figure 220.South Africa Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
  • Figure 221.South Africa Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
  • Figure 222.South Africa Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
  • Figure 223.South Africa Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
  • Figure 224.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225.By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226.By Method Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227.By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228.By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023